DOP078 Pharmacology and safety of etrasimod (APD334), an oral, potent, next-generation, selective S1P receptor modulator
Kühbacher, T., Christopher, R., Trokan, L., Lassen, C., Adams, J., Peyrin-Biroulet, L.Volume:
11
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx002.115
Date:
February, 2017
File:
PDF, 66 KB
english, 2017